As 2026 begins, the global hepatology community is closely monitoring a wave of breakthrough data from Phase II and III trials that aim to permanently correct the ATP7B genetic mutation. Regulatory authorities in the European Union and the United States have recently signaled a willingness to accept biomarker-driven endpoints, such as long-term reduction in non-ceruloplasmin bound copper, to...

Mastopexy Market Projections & Future Surgical Opportunities | MRFR MRFR projects a positive trajectory for the Mastopexy Market projections as surgical innovation and patient awareness continue to rise. Surgeons are focusing on combining proven techniques with new tools such as specialized sutures, tissue reinforcement materials, and digital outcome mapping. These innovations help deliver...